Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Day One Biopharmaceuticals (DAWN) Accumulated Depreciation & Amortization (2022 - 2023)

Day One Biopharmaceuticals (DAWN) has disclosed Accumulated Depreciation & Amortization for 2 consecutive years, with $30000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Accumulated Depreciation & Amortization changed N/A to $30000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $30000.0, a N/A change, with the full-year FY2022 number at $6000.0, changed N/A from a year prior.
  • Accumulated Depreciation & Amortization was $30000.0 for Q3 2023 at Day One Biopharmaceuticals, up from $6000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $30000.0 in Q3 2023 to a low of $6000.0 in Q4 2022.